BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15199358)

  • 21. Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting.
    Yip HK; Hung WC; Yang CH; Chen YH; Cheng CI; Chen SM; Yeh KH
    Circ J; 2005 Oct; 69(10):1202-7. PubMed ID: 16195617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term clinical outcome after implantation of medium Palmaz (biliary) stents in very large native coronary arteries.
    Chio FL; Liu MW; Al-Saif SM; Khan MA; Lawson D; Al-Mubarak N
    Catheter Cardiovasc Interv; 2002 May; 56(1):35-9. PubMed ID: 11979531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient.
    Ruygrok PN; Webster MW; Ardill JJ; Chan CC; Mak KH; Meredith IT; Stewart JT; Ormiston JA; Price S
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):165-71. PubMed ID: 12772233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.
    Liuzzo G; Buffon A; Biasucci LM; Gallimore JR; Caligiuri G; Vitelli A; Altamura S; Ciliberto G; Rebuzzi AG; Crea F; Pepys MB; Maseri A
    Circulation; 1998 Dec; 98(22):2370-6. PubMed ID: 9832480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of preprocedural fibrinogen concerning coronary stenting.
    Otsuka M; Hayashi Y; Ueda H; Imazu M; Kohno N
    Atherosclerosis; 2002 Oct; 164(2):371-8. PubMed ID: 12204810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
    Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S
    Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
    Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
    Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low rates of angiographic and clinical restenosis with the new flexible MedStent for the treatment of single discrete coronary lesions.
    Segev A; Cantor WJ; Cohen EA; Seidelin PH; Natarajan MK; Marquis JF; Lazzam C; Watson RK; Chisholm RJ; Strauss BH
    J Interv Cardiol; 2004 Jun; 17(3):167-70. PubMed ID: 15209579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris.
    Zouridakis E; Avanzas P; Arroyo-Espliguero R; Fredericks S; Kaski JC
    Circulation; 2004 Sep; 110(13):1747-53. PubMed ID: 15381646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina.
    Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F
    Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbon coating of stents has no effect on inflammatory response to primary stent deployment.
    Korkmaz ME; Tayfun E; Müderrisoglu H; Yildirir A; Ozin B; Uluçam M; Turan M
    Angiology; 2002; 53(5):563-8. PubMed ID: 12365864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics and prognostic value of inflammatory-sensitive protein, IL-6, and white blood cell levels in patients undergoing coronary stent implantation.
    Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Koskinas K; Gemitzis K; Hatzimiltiadis S; Efthimiadis G; Paraskevaidis S; Hatzitolios A; Savopoulos C; Parharidis G
    Med Sci Monit; 2009 Apr; 15(4):CR177-84. PubMed ID: 19333202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients.
    Ferrante G; Niccoli G; Biasucci LM; Liuzzo G; Burzotta F; Galiuto L; Trani C; Rebuzzi AG; Crea F
    Cardiovasc Revasc Med; 2008; 9(3):156-65. PubMed ID: 18606379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.
    Grander W; Dichtl W; Prokop W; Roithinger FX; Moes N; Friedrich G; Weidinger F; Pachinger O
    Clin Cardiol; 2004 Apr; 27(4):211-6. PubMed ID: 15119695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina.
    Goldberg A; Zinder O; Zdorovyak A; Diamond E; Lischinsky S; Gruberg L; Markiewicz W; Beyar R; Aronson D
    Am Heart J; 2003 Nov; 146(5):819-23. PubMed ID: 14597930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
    Saleh N; Tornvall P
    Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
    Spadaccio C; Patti G; De Marco F; Coccia R; Di Domenico F; Pollari F; Zanzonico R; Pettinari M; Lusini M; Di Sciascio G; Covino E; Chello M
    Am J Cardiol; 2013 Jul; 112(1):21-6. PubMed ID: 23561587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
    Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting.
    Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
    Catheter Cardiovasc Interv; 2002 Jul; 56(3):341-5. PubMed ID: 12112886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.